{"text": ["Cramer:", "I'm", "kicking", "myself", "for", "not", "recommending", "these", "stocks"], "created_at": "2019-02-28 23:44:06"}
{"text": ["Cramer:", "I'm", "kicking", "myself", "for", "not", "recommending", "these", "stocks"], "created_at": "2019-02-28 23:21:26"}
{"text": ["Aduro", "(ADRO)", "Q4", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-02-28 23:13:40"}
{"text": ["Aduro", "(ADRO)", "Q4", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-02-28 23:13:40"}
{"text": ["Aduro", "(ADRO)", "Q4", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-02-28 21:13:09"}
{"text": ["What\u2019s", "Expected", "for", "AstraZeneca\u2019s", "or", "Eli", "Lilly\u2019s", "EPS", "Growth"], "created_at": "2019-02-28 19:45:02"}
{"text": ["Woburn's", "Abpro", "strengthens", "Chinese", "ties", "with", "immuno-oncology", "deal"], "created_at": "2019-02-28 19:44:59"}
{"text": ["Drug", "Price", "Debate:", "is", "Legislation", "Necessary?"], "created_at": "2019-02-28 19:28:33"}
{"text": ["Will", "AstraZeneca", "or", "Eli", "Lilly", "Report", "More", "Revenue", "Growth?"], "created_at": "2019-02-28 18:15:02"}
{"text": ["United", "Therapeutics", "(UTHR)", "Q4", "Earnings", "&", "Sales", "Beat", "Estimates"], "created_at": "2019-02-28 17:16:20"}
{"text": ["United", "Therapeutics", "(UTHR)", "Q4", "Earnings", "&", "Sales", "Beat", "Estimates"], "created_at": "2019-02-28 17:16:20"}
{"text": ["Analysts\u2019", "Recommendations", "for", "AstraZeneca", "and", "Eli", "Lilly"], "created_at": "2019-02-28 16:44:52"}
{"text": ["United", "Therapeutics", "(UTHR)", "Q4", "Earnings", "&", "Sales", "Beat", "Estimates"], "created_at": "2019-02-28 15:16:03"}
